Home » Topics » Conferences

Conferences
RSS

New factor Xa inhibitors designed at DuPont Merck

April 8, 1998

HBOC-201 reduces need for blood transfusions in surgery

April 8, 1998

Novel PDE IV inhibitors in the pipeline at Jouveinal/Parke-Davis

April 8, 1998

RPR-130737, a potent nonpeptidyl inhibitor of factor Xa

April 7, 1998

Merck & Co. designates thrombin inhibitor for clinical development

April 7, 1998

Pfizer NK1 antagonist and ondansetron provide synergistic antiemetic efficacy in clinical trials

April 7, 1998

Early clinical trial evaluates orbofiban pharmacodynamics

April 7, 1998

First clinical trials performed with BMS-181885

April 7, 1998

Phase Ib results reported for allosteric Hb modifier RSR13

April 7, 1998

Novel antisecretory/antiulcer agent from Shionogi undergoes evaluation in Japan

April 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...